INS and preeclampsia: No clear trend regarding the effectiveness of continuous subcutaneous insulin infusion can be derived regarding pregnancy- and birth-related outcomes such as maternal weight gain, preterm births, cesarean delivery, maternal hypertension, or preeclampsia.